the way the agency is structured; (3) the importance of improving information and communication about benefits and risks; (4) public–private collaboration so stakeholders can work together to accomplish shared goals; and (5) the agency’s regulatory authority.
The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Pray, Leslie, Robinson, Sally "
Challenges for the FDA: The Future of Drug Safety, Workshop Summary . Washington, DC: The National Academies Press,
Please select a format: